JP Morgan reduced its stake in INNOVENT BIO (01801) by approximately 15,536,100 shares, with an average price of around HK$43.05 per share.
On September 11, Xiaomi reduced its holdings in Sino Biopharmaceutical (01801) by 15,536,147 shares, with a price of HK$43.0477 per share, totaling approximately HK$669 million.
According to the latest data from the Hong Kong Stock Exchange, on September 11, JP Morgan reduced its holdings of INNOVENT BIO (01801) by 15,536,147 shares, at a price of 43.0477 Hong Kong dollars per share, for a total amount of approximately 669 million Hong Kong dollars. After the reduction, the latest number of shares held is approximately 87,805,600 shares, with a latest shareholding percentage of 5.38%.
Related Articles
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
